With its growing comprehensive portfolio of high-quality, high-technology, easyto- use and affordable products, Nihon Kohden is committed to fighting disease with electronics, says Anil Srivastava, National Sales Manager, Medical Equipment, Nihon Kohden India
On August 7, 1951, Nihon Kohden was founded with the goal of Fighting Disease with Electronics. With more than 60 years’ innovations and product development, Nihon Kohden has become one of the significant global medical equipment manufacturers and one of the largest Japanese medical devices providers. Its success has been deeply rooted in its commitment to invest in R&D every year for continuous innovative product development. Nihon Kohden R&D centers, scientists and engineers are working towards innovations and regular improvisation of technology.
We focus on providing quality medical services for Indian market; since India with world’s second largest population has become one of the most important global economic propellers. In order to further deliver better healthcare solutions for their clients in India, from pre-sales to customer services, Nihon Kohden Corporation Japan set the Indian subsidiary in April 2011 as Nihon Kohden India Pvt. Ltd. By endless pursuits for high quality and technology, their products have gained good recognition and reputation in Indian market.
In short period of just 48 months’ operation, the technology provider has got fantastic business from all segment of customers including many prestige hospital like AIIMS, New Delhi; Apollo Group of Hospitals; Ruby Hall Clinic, Pune; Prince Aly Khan Hospital, Mumbai; MIOT Hospital, Chennai; Fortis Healthcare; Paras Healthcare, Gurgaon, Delhi, Patna; Madras Medical Mission, Chennai; JIPMAR, Pondicherry; PGIMER, Chandigarh; SCTIMST, Thiruvananthapuram; Christian Medical Collage, Ludhiana; Dayanand Medical Collage, Ludhiana etc.
Nihon Kohden is redefining qualityof- care with new, innovative technology – esCCO, by introducing volumetric information to all care levels. With esCCO, the quality of hemodynamic monitoring will be improved for all care levels. Emphasis is on non-invasive techniques to measure important parameters like Continuous Cardiac Output (CCO) is growing. Recent reports show that usage of the pulmonary artery catheter declined 65 per cent from 1993 to 2004 in the USA. The ambition in R&D though, was the provision of volumetric information, especially for mid and low care levels, to improve patient care and enhance treatment outcome. With that, the challenge was to avoid any kind of invasive or minimal-invasive calibration.
By only entering patient information such as age, gender, height and weight, and an initial NIBP measurement, esCCO determines a reference value for calibration and is ready for start the measurement. Additionally, a cardiac output value obtained by other CO devices such as by pulmonary artery catheter can be used for calibration. Both calibration modes reliably track changes in cardiac output and provide advanced monitoring of a patient’s hemodynamic status, thus helping clinicians in better patient care.
Futuristic in Outlook
With investment in R&D, quality has always been their first priority. As a medical equipment manufacturer, the quality of their products is not only vital for patient’s life but also a vital part of Japanese quality culture. We intends to keep growing as a leading medical electronic equipment company by developing innovative products based on their engineering specialty, the human-machine interface; developing competitive, high quality products in core market areas and using strong distribution network and experience in medical equipment to expand into a wider range of markets.